|
|
|
|
| Cat. No. 292 003 |
50 µg specific antibody, lyophilized. Affinity purified with the immunogen. Albumin and azide were added for stabilization. For reconstitution add 50 µl H2O to get a 1mg/ml solution in PBS. Then aliquot and store at -20°C to -80°C until use. Antibodies should be stored at +4°C when still lyophilized. Do not freeze! |
| Applications | |
| Immunogen | Synthetic peptide corresponding to AA 242 to 259 from mouse Olig2 (UniProt Id: Q9EQW6) |
| Reactivity |
Reacts with: rat (G3V612), mouse (Q9EQW6). Other species not tested yet. |
| Data sheet | Data Sheet 292_003 |
|
|
Olig2 (also known as BHLHB1 and PRKCBP2) is a basic helix–loop–helix transcription factor characteristic of the oligodendroglial lineage and plays key roles in the specification and maturation of oligodendrocytes. Oligodendrocytes are glial cells that produce and maintain central nervous system myelin; Morphologically, oligodendrocyte nuclei are typically smaller and more oval than nuclei of other CNS cell types. (1-3).
In cancer, particularly in diffuse gliomas, Olig2 is widely used as a nuclear immunohistochemical marker of glial lineage. In diagnostic pathology, nuclear Olig2 immunohistochemistry is widely used as a glial lineage marker in diffuse gliomas: Olig2 is strongly expressed in oligodendrogliomas and is also detectable in a substantial proportion of astrocytomas and glioblastomas (GBM). Large cohorts established that Olig2 is highly expressed across diffuse gliomas while being largely restricted to oligodendroglia in normal brain, supporting its utility in routine practice (4, 5).
For more information on protein expression pattern, please refer to the overview image in our SYSY Antibodies ATLAS.